Suchergebnisse - "Herrington, William G"

PubPharm (7)

1

Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

enthalten in: Journal of the American Society of Nephrology : JASN | 2024

von Mayne, K. | Staplin, N. | Keane, D. | +128

2

Empagliflozin in Patients with Chronic Kidney Disease

enthalten in: The New England journal of medicine | 2023

von The EMPA-KIDNEY Collaborative Group | Herrington, W. | Staplin, N. | +137

CommentIn: Nat Rev Nephrol. 2023 Jan;19(1):3. - PMID 36450917

3

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2022

von EMPA-KIDNEY Collaborative Group | Herrington, W. | Wanner, C. | +98

4

Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors : a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitors

enthalten in: European journal of heart failure | 2021

von Herrington, W. | Savarese, G. | Haynes, R. | +9

5

Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease

enthalten in: Circulation | 2018

von Haynes, R. | Judge, P. | Staplin, N. | +13

CommentIn: Circulation. 2018 Oct 9;138(15):1515-1518. - PMID 30354525

6

Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2018

von 3C Study Collaborative Group | Haynes, R. | Blackwell, L. | +9

7

Effects of lowering LDL cholesterol on progression of kidney disease

enthalten in: Journal of the American Society of Nephrology : JASN | 2014

von Haynes, R. | Lewis, D. | Emberson, J. | +65

1
[1]